Unknown

Dataset Information

Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints.


ABSTRACT: Severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 is a virus that belongs to the Coronaviridae family. This group of viruses commonly causes colds but possesses a tremendous pathogenic potential. In humans, an outbreak of SARS caused by the SARS-CoV virus was first reported in 2003, followed by 2012 when the Middle East respiratory syndrome coronavirus (MERS-CoV) led to an outbreak of Middle East respiratory syndrome (MERS). Moreover, COVID-19 represents a serious socioeconomic and global health problem that has already claimed more than four million lives. To date, there are only a handful of therapeutic options to combat this disease, and only a single direct-acting antiviral, the conditionally approved remdesivir. Since there is an urgent need for active drugs against

SUBMITTER: Jukic M 

PROVIDER: S-EPMC8748264 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature